52
Participants
Start Date
August 31, 2002
Primary Completion Date
February 29, 2004
Study Completion Date
February 29, 2004
Imiquimod 5% cream
Subjects were treated with imiquimod (one sachet/20 cm2), three applications per week, for up to 16 weeks, or fewer in the case of total clearance of initial warts. At the visit at the end of treatment, a second scraping of the lesion area was carried out to determine the sub-type of HPV.
Départment de Gynécologie-Obstétrique CHU Saint-Pierre, Brussels
Service de Dermatologie CHU Saint-Pierre, Brussels
Service Dermatologie C.H. François Rabelais (César de Paepe), Brussels
Service de Dermatologie Hôpital Erasme, Brussels
Service de Dermatologie et Vénéréologie Hôpital Saint Jacques, Besançon
Cabinet Médical, Bordeaux
Service de Dermatologie, Hôpital Ambroise Paré, Boulogne-Billancourt
Service de Maladies Infectieuses Hôpital de la Conception, Marseille
Service de Dermatologie Hôtel Dieu, Nantes
Service de Dermatologie Hôpital de l'Archet II, Nice
Service Dermatologie Hopital COCHIN - Pavillon Tarnier, Paris
Cabinet Médical, Paris
Institut Alfred Fournier, Paris
Cabinet Médical, Paris
Service de Dermatologie Groupe Hospitalier Bichat Claude Bernard, Paris
Service de Dermatologie Hopital Tenon, Paris
Service de Dermatologie Groupe Hospitalier La Grave, Toulouse
Service de Dermatologie Centre Hospitalier de Valence, Valence
ORION Sante
UNKNOWN
MEDA Pharma GmbH & Co. KG
INDUSTRY